Is Direct Meds Legit? What Our Registry Shows (2026)

Is Direct Meds a real, safe GLP-1 telehealth company? Verified pricing history, including a 2026-07-16 price reversion caught after its homepage stopped showing prices, refund policy, states served, and independent Trustpilot + BBB records, sourced from RangeYourself’s dated registry.

By RangeYourselfLast verified July 25, 2026

Yes, Direct Meds is a real, operating GLP-1 telehealth company. RangeYourself has independently verified its pricing directly against its own site since July 3, 2026, most recently on July 25, 2026, and its refund/cancellation terms and states served are published on its own site, the evidence for that verdict is the dated verification trail below, not a claim we're asking you to take on faith.

How long we’ve tracked Direct Meds

RangeYourself first recorded a verified price for Direct Meds on July 3, 2026, sourced directly from Direct Meds’s own site. Since then we’ve logged 2 dated price checks on this program, most recently July 25, 2026. That dated trail , not a one-time snapshot, is what a legitimacy check on a telehealth program should rest on.

Pricing verification history

July 3, 2026: $179/mobaseline snapshot, price-history tracking began 2026-07-14; seeded from the current verified price only (no prior prices invented)
July 16, 2026: $249/moVerified live 2026-07-16 on Direct Meds' own product pages: sublingual semaglutide now $249.00/mo and sublingual tirzepatide $299.00/mo, each marked '0% OFF / Billed Every Month'. The previously verified $179.10/$224.10 figures (a 10%-off rate, 2026-07-03) are no longer offered; injections unchanged ($297/$399). The /solutions/weight-loss page states the same $249 sublingual entry. This reversion had been invisible to the nightly audit because directmeds.com's homepage renders no prices (dead read), the audit now checks the sublingual product page (priceCheckUrl).

Refund and cancellation policy

Direct Meds’s own stated policy: No refund on dispensed compounded medication

Price and terms on file

Price: $249/mo (sublingual all-inclusive rate)

Membership fee: No separate membership fee

Price last verified: July 25, 2026

States served

Direct Meds ships to all US states except Mississippi and Louisiana, per its own site (verified July 25, 2026).

What the records show

Direct Meds carries a large, consistent Trustpilot base alongside a solid BBB grade with a notable complaint volume for a company its size, worth reading in context of its scale, not as an isolated red flag.

Trustpilot: 4.6★ (12,546 reviews) via Trustpilot, checked 2026-07-24

BBB: B+ rating (not accredited), BBB profile, checked 2026-07-24

Listed as "Direct Meds LLC" (telemedicine, Salt Lake City, UT); 260 complaints noted in the rating-reasons section. Other "Direct Meds" BBB entities exist under different corporate names/locations, this is the telemedicine listing matching directmeds.com's business model.

Independently observed third-party data, not our own editorial score. Full methodology: GLP-1 Provider Reliability Report.

Verified programs with a published all-in monthly price

Direct Meds does not publish a single comparable all-in monthly price: pricing varies materially by medication format (sublingual vs injection) and by page (product-page all-inclusive rate vs homepage promo card), no single canonical recurring price to publish. The programs below do, verified on each provider’s own pricing page and ranked lowest first as of September 14, 2026.

1.Embody
$69/mo (limited-time promo), verified September 5, 2026
See pricing →
2.Strut Health
$99/mo (sublingual/oral starting price), verified August 21, 2026
See pricing →
3.Trimi
$99/mo (annual-plan rate), verified August 21, 2026
See pricing →
4.HealthRX
$99/mo (12-month plan rate), verified August 21, 2026
See pricing →
5.bmiMD
$119/mo (12-month plan rate), verified September 3, 2026
See pricing →

Prices are each provider’s own published all-in monthly figure at the plan term shown, verified on the date listed. RangeYourself may earn a commission from some programs; that can only break an exact tie between verified equals and never changes the price order.

See Direct Meds pricing → Read the full Direct Meds review →

Frequently asked questions

Is Direct Meds a real company?

Yes. RangeYourself has independently verified Direct Meds's pricing directly against its own site (directmeds.com), first checked July 3, 2026 and most recently re-verified July 25, 2026, across 2 dated price checks on file, and its refund policy and states served are published on its own site.

Is Direct Meds FDA-approved?

No. Direct Meds prescribes compounded semaglutide and/or tirzepatide via state-licensed 503A pharmacies or 503B outsourcing facilities. Compounded medication is not individually FDA-approved as a finished product. The shortage-era compounding pathway ended after the FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so compounding now proceeds under the ordinary rules for individual patients.

Does Direct Meds offer refunds or a guarantee?

Direct Meds's own stated policy: No refund on dispensed compounded medication This is the program's own policy, not a promise from RangeYourself, confirm current terms directly with Direct Meds before enrolling.

What do independent reviews show for Direct Meds?

4.6★ on Trustpilot from 12,546 reviews (checked 2026-07-24). A B+ BBB grade (not BBB Accredited) (checked 2026-07-24). This is third-party data, not RangeYourself's own editorial score.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. This legitimacy check reflects registry data verified through July 25, 2026 and may change.